Menu

Senate, House Propose Funding Boosts for US Science Agencies

NASA, NSF, and NIH are expected to receive higher financial backing for the 2019 fiscal year, going above and beyond the President’s proposed budget.  

Jun 17, 2018
Sukanya Charuchandra

ISTOCK, ISAK55A US Senate subcommittee approved a funding bill on June 12 that includes budget improvements for space and science research in 2019. Further, the House Appropriations Committee drafted a spending bill for 2019 that boosts funding for the National Institutes of Health (NIH).

The Senate Appropriations panel has allotted $21.3 billion for NASA, more than $500 million above the enacted amount for fiscal year 2018 and $1.43 billion above President Donald Trump’s requested budget, according to Science. If this bill is passed, the National Science Foundation would get $8.1 billion, which is $301 million above the last fiscal year’s enacted level and $597 million beyond the President’s request.

The House’s spending bill released on June 14 for the NIH grants the agency $38.3 billion, which is $1.25 billion more than the previous fiscal year and $4.1 billion above that requested by Trump. The Centers for Disease Control and Prevention would receive $7.6 billion, down $663 million from the 2018 fiscal year, but still $2 billion higher than the President’s request.

Francis Collins, the NIH director, tells Science, that the Senate tends to go higher than the House’s budget for the NIH, taking this allotment “on a very positive trajectory.” A Senate committee will discuss its NIH funding proposal next week.

According to Science, researchers are pleased about the increase in NIH’s funding but worried about a possible ban on research using fetal tissue obtained from elective abortions.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.